Search results for "Highlights"
Inhaled insulin noninferior to usual care, industry trial in type 1 diabetes finds
Patients who began using inhaled insulin were more likely to have an improvement or worsening in their HbA1c level than patients who continued their existing insulin regimens, but overall glycemic control was similar with either strategy, a randomized trial found.
https://diabetes.acponline.org/archives/2024/12/13/3.htm
13 Dec 2024
Subscribe
ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.
https://diabetes.acponline.org/subscribe/index.html
Hypoglycemic events linked to subsequent stroke risk in diabetes
Medicare patients with diabetes who had a hypoglycemic event had higher odds of a subsequent acute ischemic stroke. Risk was highest on the day after the event and decreased with time but persisted for 30 days, the case-crossover study found.
https://diabetes.acponline.org/archives/2024/12/13/2.htm
13 Dec 2024
Diabetes rates hold steady in latest U.S. report, rising around the world
In the U.S., 11.3% of adults have diagnosed diabetes and 4.5% have undiagnosed diabetes, a CDC report found. A global analysis found that diabetes rates are rising fastest in low- and middle-income countries in southeast Asia, south Asia, the Middle East and north Africa, and Latin America and the Caribbean.
https://diabetes.acponline.org/archives/2024/12/13/1.htm
13 Dec 2024
Report and study highlight risk of heart failure in patients with diabetes
The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
https://diabetes.acponline.org/archives/2022/06/10/1.htm
10 Jun 2022
Review calls for increased measurement, treatment of diabetes distress
An analysis of six studies found that an average of 78.3% of people with diabetes had at least some clinically relevant diabetes distress-related problems and that a commonly used scale does not capture most patients with distress.
https://diabetes.acponline.org/archives/2024/11/08/3.htm
8 Nov 2024
Dexamethasone not associated with survival benefit in inpatients with COVID-19, diabetes
Patients with diabetes and severe COVID-19 who were treated with dexamethasone had slower time to clinical recovery than propensity-matched patients who didn't get dexamethasone, and steroid treatment did not improve mortality, a retrospective study found.
https://diabetes.acponline.org/archives/2024/11/08/2.htm
8 Nov 2024
Metformin linked with lower delirium risk in older patients with type 2 diabetes
There was a dose-response relationship between metformin and delirium in those ages 65 years and older, with higher cumulative and daily doses of the medication linked with lower delirium risk, a cohort study in Taiwan indicated.
https://diabetes.acponline.org/archives/2024/10/11/3.htm
11 Oct 2024
Spotlight on liver health in diabetes
A review compared liver outcomes for most classes of diabetes drugs, while a retrospective study looked at glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors head to head. Another study offered a new score for metabolic dysfunction-associated steatotic liver disease.
https://diabetes.acponline.org/archives/2024/10/11/5.htm
11 Oct 2024
Diabetes-related foot ulcers associated with high short-term mortality rates
In patients with a new diabetes-related foot ulcer, mortality rates were 4.2%, 8.2%, and 14.4% at 12, 26, and 52 weeks, and even higher rates were seen with cardiovascular or renal comorbidities or older age, a study in England and Wales found.
https://diabetes.acponline.org/archives/2024/10/11/2.htm
11 Oct 2024